期刊文献+

卵巢外腹膜浆液性乳头状癌与卵巢浆液性乳头状癌比较分析 被引量:8

Comparison of primary extraovarian peritoneal serous papillary carcinoma with stage Ⅲ-Ⅳ ovarian papillary serous carcinoma
原文传递
导出
摘要 目的 探讨卵巢外原发腹膜浆液性乳头状癌 (EPSPC)的临床和治疗特点及预后。方法回顾性分析 12例EPSPC与 4 5例Ⅲ、Ⅳ期卵巢浆液性乳头状癌 (OPSC)的临床和随访资料 ,比较其临床及治疗特点、对一线化疗药物的敏感性及生存时间。结果 EPSPC与OPSC两组的症状、体征、CA12 5水平、无瘤期、复发时间、对一线化疗药物的反应及生存时间差异无统计学意义 ,而EPSPC组的完全缓解率 (2 5 .0 % )与OPSC组 (91.8% )比较 ,显著降低 (P <0 .0 1)。结论 EPSPC与OPSC临床过程类似 ,当治疗手段相同时 ,对一线化疗药物的敏感性及生存时间相近。 Objective Extraovarian peritoneal serous papillary carcinoma (EPSPC) is both histologically and clinically similar to stage Ⅲ Ⅳ ovarian papillary serous carcinoma (OPSC). The purpose of this study is to investigate the clinical findings, treatment, and outcome of EPSPC patients compared with stage Ⅲ Ⅳ OPSC patients. Methods The data of 12 EPSPC patients and 45 stage Ⅲ Ⅳ OPSC patients were retrospectively reviewed, comparing the characteristics on clinical presentation and treatment, sensitivity to first line chemotherapy agents and survival. Results By analysis of patients′ characteristics, presenting signs and symptoms, type and extent of surgery, tumor response to first line chemotherapy, recurrence free interval, recurrence site and serum CA 125 levels, no significant difference was observed between the EPSPC patients and stage Ⅲ Ⅳ OPSC controls. The prevailing presenting symptoms were abdominal mass and ascites. The mainstay of treatment was debulking surgery followed by adjuvant platinum based chemotherapy. The complete clinical response of stage Ⅲ Ⅳ OPSC was 91.8% compared with 25.0% for women with EPSPC( P <0.01). Conclusion The clinical and surgical characteristics of EPSPC are similar to those of stage Ⅲ Ⅳ OPSC. When the same treatment strategy is applied, similar response and survival are expected in either condition.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2005年第3期171-173,共3页 Chinese Journal of Oncology
关键词 临床 化疗药物 生存时间 卵巢外腹膜浆液性乳头状癌 治疗特点 复发时间 随访资料 结论 比较分析 水平 Peritoneal neoplasms Ovarian papillary serous carcinoma Prognosis
  • 相关文献

参考文献10

  • 1Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary: case report. Am J Obstet Gynecol,1959, 77: 197-200.
  • 2Eltabbakh GH, Piver MS, Natarajan N, et al. Epidemiololgic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol,1998, 91: 254-259.
  • 3Moll UM, Valea F, Chumas J. Role of p53 alteration in primary peritoneal carcinoma. Int J Gynecol Pathol, 1997, 16: 156-162.
  • 4Piura B, Meirovitz M, Bartfeld M, et al. Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage Ⅲ-Ⅳ ovarian papillary serous carcinoma. J Surg Oncol, 1998, 68: 173-178.
  • 5Halperin R, Zehavi S, Langer R, et al. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer,2001, 11: 403-408.
  • 6Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med,2002, 346: 1616-1622.
  • 7Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal serous papillary carcinoma: a phase Ⅱ trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecol Oncol, 2003,89: 148-154.
  • 8Weir MM, Bell DA, Young RH. Grade 1 peritoneal serous carcinomas:a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors. Am J Surg Pathol, 1998,22: 849-862.
  • 9吴燕,李蔚范.原发性腹膜恶性肿瘤28例临床分析[J].癌症,2003,22(11):1228-1231. 被引量:12
  • 10李洪君,吴令英,刘丽影,章文华,张容,李晓光,石素胜.原发性腹膜癌15例临床诊治分析[J].中国肿瘤临床,2002,29(7):504-506. 被引量:10

二级参考文献14

  • 1张贵宇,江森,王波,王美清,王鸿云.卵巢外腹膜浆液性乳头状癌11例临床分析[J].中华妇产科杂志,1996,31(12):707-710. 被引量:24
  • 2石雪君,郭燕燕,李竞贤,汤秀英,张莹,尹玲.卵巢外腹膜浆液性乳头状癌的临床及病理学分析[J].中华妇产科杂志,1996,31(12):711-713. 被引量:22
  • 3朱燕宁.女性腹膜的原发性肿瘤[J].中华妇产科杂志,1996,31(12):750-752. 被引量:28
  • 4Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary[J]. Gynecol Oncol, 1993,50(3) :347 - 351.
  • 5Lauehlan SC. The secondary Mullerian system revisited[J]. Int J Gynecol Pathol, 1994,13 ( 1 ) : 73 - 79.
  • 6Pickartz H. Differential diagnosis of peritoneal lesions of Mullerian type and similar epithelial tumors of the peritoneum [J]. Int J Gynecol Pathol,1993,12(2):116-119.
  • 7Wang PH, Liu RS, Li YF, et al. Whole-body PET with ( fluorine- 18 ) -2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report[J]. Gynecol Oncol, 2000,77(1):44 -47.
  • 8Altaras MM, Aviram R, Cohen I, et al. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects[J]. Gynecol Oncol, 1991,40(3) :230 - 236.
  • 9Killackey MA, Davis AR. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma[J]. Gynecol Onco1,1993,51(2): 171 - 174.
  • 10Ben-Baruch G, Sivan E, Moran O, et al. Primary peritoueal serous papillary carcinoma: a study of 25 cases and comparison with stage Ⅲ - Ⅳ ovarian papillary serous carcinoma [ J ]. Gynecol Oncol, 1996,60 (3) : 393 - 396.

共引文献20

同被引文献48

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部